The probiotic
Pediococcus pentosaceus GS4 MTCC 12683 (Genbank accession no: HMO44322) was cultured in De Mann Rogosa Sharpe broth/agar at 37°C following standard microbiological procedures. CLA
GS4 was prepared as reported elsewhere [11 (
link)]. The human CC cell line HCT-116, which was procured from the National Centre for Cell Science, Pune, India, and was maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% (v/v) heat inactivated Fetal bovine serum (FBS) and 100
μg/mL of streptomycin and 10 U/mL of penicillin at 37°C in 5% CO
2 atmosphere (CO
2 incubator, Sanyo, Osaka, Japan). The CLA (mixture of
trans-10,
cis-12 and
cis-9,
trans-11 CLA), linoleic acid, and bisphenol A diglycidyl ether (BADGE) were purchased from Sigma (St. Louis, MO, USA). The acridine orange (AO), ethidium bromide (EtBr), propidium iodide (PI), 4′,6-diamidino-2-phenylindole, 2′,7′-dichlorofluorescin diacetate, and Rhodamine-123 (Rh123) were cell culture grade purchased from HiMedia, Mumbai, India. Primary antibodies against PPAR
γ (CST 2435), 5-LOX (3289), NF-
κB (8242), p53 (2524), p21
WAF (37543), Bax (2772), Bcl
2 (15071), cleaved Poly (ADP-ribose) polymerase (PARP) (5625), caspase 3 (9662), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (5174) were purchased from Cell Signaling Technology (Beverly, MA, USA). The COX-2 primary antibody was obtained from TaKaRa, Shiga, Japan. The Pierce TMB-Blotting 1-step solution (34018) was procured from Thermo Fisher, Massachusetts, USA.
Dubey V., Mishra A.K, & Ghosh A.R. (2023). Appraisal of the Possible Role of PPARγ Upregulation by CLA of Probiotic Pediococcus pentosaceus GS4 in Colon Cancer Mitigation. PPAR Research, 2023, 9458308.